title: [First-line therapy for low-risk prostate cancer: prospective phase II study of focal therapy (hemiablation) of the prostate with high intensity focused ultrasound (HIFU) in patients suitable for "Active Surveillance" (AP 68/11 of the AUO)].
authors.affiliation: Geschäftsstelle der AUO, MeckEvidence, Seestraße 11, 17252, Schwarz, Deutschland, AUO@MeckEvidence.de.
authors.forename: H
authors.initials: H
authors.lastname: Rexer
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D057086:High-Intensity Focused Ultrasound Ablation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000628:therapy*; D018570:Risk Assessment; D016896:Treatment Outcome; D055815:Young Adult
vernacular_title: First-line-Therapie beim Low-risk-Prostatakarzinom: Prospektive Phase-II-Studie zur fokalen Therapie (Hemiablation) der Prostata durch hochintensiven fokussierten Ultraschall bei Patienten mit Eignung zur "Active Surveillance" (AP 68/11 der AUO).